Intech Investment Management LLC Has $560,000 Position in DENTSPLY SIRONA Inc. $XRAY

Intech Investment Management LLC lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 81.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 49,005 shares of the medical instruments supplier’s stock after selling 216,973 shares during the quarter. Intech Investment Management LLC’s holdings in DENTSPLY SIRONA were worth $560,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in DENTSPLY SIRONA by 4.1% during the third quarter. Vanguard Group Inc. now owns 22,006,576 shares of the medical instruments supplier’s stock valued at $279,263,000 after purchasing an additional 869,566 shares during the period. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 3.2% during the fourth quarter. First Eagle Investment Management LLC now owns 14,640,555 shares of the medical instruments supplier’s stock valued at $167,342,000 after purchasing an additional 458,744 shares during the period. AQR Capital Management LLC grew its holdings in DENTSPLY SIRONA by 109.8% during the second quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock valued at $211,470,000 after purchasing an additional 6,970,086 shares during the period. Lazard Asset Management LLC grew its holdings in DENTSPLY SIRONA by 0.9% during the third quarter. Lazard Asset Management LLC now owns 10,200,525 shares of the medical instruments supplier’s stock valued at $129,445,000 after purchasing an additional 92,868 shares during the period. Finally, State Street Corp grew its holdings in DENTSPLY SIRONA by 5.5% during the second quarter. State Street Corp now owns 7,099,906 shares of the medical instruments supplier’s stock valued at $113,868,000 after purchasing an additional 369,876 shares during the period. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the subject of a number of analyst reports. Barrington Research boosted their price objective on shares of DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a report on Monday, March 2nd. Bank of America upgraded shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $13.00 to $17.00 in a report on Thursday, February 19th. Barclays decreased their price objective on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating for the company in a report on Thursday, June 4th. Wells Fargo & Company upped their price target on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Finally, Weiss Ratings cut shares of DENTSPLY SIRONA from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 6th. Three investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.55.

DENTSPLY SIRONA Stock Up 2.0%

DENTSPLY SIRONA stock opened at $10.47 on Wednesday. The stock has a market capitalization of $2.10 billion, a PE ratio of -3.32, a price-to-earnings-growth ratio of 1.22 and a beta of 0.89. DENTSPLY SIRONA Inc. has a twelve month low of $9.40 and a twelve month high of $17.09. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52. The company has a 50 day moving average of $11.07 and a 200-day moving average of $11.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.28 by ($0.01). The company had revenue of $880.00 million during the quarter, compared to analyst estimates of $841.80 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The firm’s quarterly revenue was up .1% compared to the same quarter last year. During the same quarter last year, the company earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current fiscal year.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.